We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.8B
AUM Growth
+$988M
Cap. Flow
+$812M
Cap. Flow %
7.54%
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$32.7M
2
LLY icon
Eli Lilly
LLY
+$31M
3
LZB icon
La-Z-Boy
LZB
+$17.4M
4
UI icon
Ubiquiti
UI
+$17.1M
5
TRS icon
TriMas Corp
TRS
+$16.1M

Top Sells

Rank Stock Value
1
LXU icon
LSB Industries
LXU
+$14M
2
K
Kellanova
K
+$13.7M
3
AAPL icon
Apple
AAPL
+$13.1M
4
PB icon
Prosperity Bancshares
PB
+$11.7M
5
FLR icon
Fluor
FLR
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 12.7%
3 Healthcare 12.22%
4 Financials 10.93%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPXL
1151
DELISTED
Impax Laboratories, Inc.
IPXL
$166K ﹤0.01%
6,304
-13,375
-68% -$334K
BIP icon
1152
Brookfield Infrastructure Partners
BIP
$19.1B
$164K ﹤0.01%
10,534
+2,268
+27% +$33.9K
AMJ
1153
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$164K ﹤0.01%
3,548
+86
+2% +$3.97K
BN icon
1154
Brookfield
BN
$104B
$163K ﹤0.01%
17,085
KMT icon
1155
Kennametal
KMT
$2.7B
$163K ﹤0.01%
3,700
+1,440
+64% +$65.9K
STMP
1156
DELISTED
Stamps.com, Inc.
STMP
$163K ﹤0.01%
4,896
-4,298
-47% -$162K
XEL icon
1157
Xcel Energy
XEL
$50.6B
$162K ﹤0.01%
5,377
-100
-2% -$2.92K
ALNY icon
1158
Alnylam Pharmaceuticals
ALNY
$38.2B
$161K ﹤0.01%
2,400
-300
-11% -$23.2K
SDY icon
1159
State Street SPDR S&P Dividend ETF
SDY
$22.3B
$161K ﹤0.01%
2,210
+1,250
+130% +$89.9K
TEF
1160
DELISTED
Telefonica
TEF
$161K ﹤0.01%
14,034
+75
+0.5% +$863
CTRX
1161
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$161K ﹤0.01%
3,618
+3,369
+1,353% +$162K
EWA icon
1162
iShares MSCI Australia ETF
EWA
$1.39B
$160K ﹤0.01%
6,200
FBIN icon
1163
Fortune Brands Innovations
FBIN
$6.13B
$160K ﹤0.01%
4,462
-127
-3% -$4.88K
EW icon
1164
Edwards Lifesciences
EW
$48.2B
$159K ﹤0.01%
12,900
HIBB
1165
DELISTED
Hibbett, Inc. Common Stock
HIBB
$159K ﹤0.01%
3,008
ICLR icon
1166
Icon
ICLR
$13.9B
$158K ﹤0.01%
3,339
IDV icon
1167
iShares International Select Dividend ETF
IDV
$8.28B
$158K ﹤0.01%
4,100
RMBS icon
1168
Rambus
RMBS
$9.43B
$158K ﹤0.01%
14,700
HOT
1169
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$158K ﹤0.01%
2,004
+520
+35% +$40.7K
TNH
1170
DELISTED
Terra Nitrogen
TNH
$157K ﹤0.01%
1,034
EWC icon
1171
iShares MSCI Canada ETF
EWC
$6.17B
$156K ﹤0.01%
5,305
HOUS
1172
DELISTED
Anywhere Real Estate
HOUS
$156K ﹤0.01%
3,622
+290
+9% +$13.5K
CASY icon
1173
Casey's General Stores
CASY
$31.8B
$155K ﹤0.01%
2,303
+868
+60% +$58.8K
IONS icon
1174
Ionis Pharmaceuticals
IONS
$8.97B
$155K ﹤0.01%
3,608
+400
+12% +$19.4K
FXF icon
1175
Invesco CurrencyShares Swiss Franc Trust
FXF
$409M
$153K ﹤0.01%
1,390

Similar funds

Glenmede Trust's Q1 2014 Portfolio in Review

As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.

  • Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
  • Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
  • Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
  • Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
  • Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
  • Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
  • Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.

Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.